Anteris Technologies Global Corp. (NASDAQ:AVR – Get Free Report) major shareholder L1 Capital Pty Ltd sold 23,000 shares of the stock in a transaction on Friday, July 24th. The shares were sold at an average price of $8.13, for a total transaction of $186,990.00. Following the sale, the insider directly owned 7,789,000 shares of the company’s stock, valued at $63,324,570. The trade was a 0.29% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
Anteris Technologies Global Stock Performance
AVR stock opened at $8.17 on Wednesday. The stock has a market capitalization of $795.28 million, a price-to-earnings ratio of -3.66 and a beta of 1.65. The firm’s 50-day moving average price is $9.28 and its two-hundred day moving average price is $7.09. Anteris Technologies Global Corp. has a 12-month low of $2.99 and a 12-month high of $11.06.
Anteris Technologies Global (NASDAQ:AVR – Get Free Report) last posted its earnings results on Tuesday, May 12th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.01). The business had revenue of $0.49 million during the quarter, compared to the consensus estimate of $0.77 million. Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.During the same period in the previous year, the business earned ($0.61) earnings per share. Equities analysts predict that Anteris Technologies Global Corp. will post -1.14 EPS for the current year.
Institutional Trading of Anteris Technologies Global
Analysts Set New Price Targets
Several analysts recently weighed in on AVR shares. Barclays lifted their price target on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Wall Street Zen upgraded shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Anteris Technologies Global in a research note on Friday, May 29th. Four research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $16.00.
Check Out Our Latest Report on Anteris Technologies Global
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
See Also
- Five stocks we like better than Anteris Technologies Global
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
